nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Lisinopril—systemic scleroderma	0.117	0.228	CbGbCtD
Reboxetine—ABCB1—Captopril—systemic scleroderma	0.0876	0.171	CbGbCtD
Reboxetine—CYP2D6—Captopril—systemic scleroderma	0.0826	0.161	CbGbCtD
Reboxetine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.069	0.134	CbGbCtD
Reboxetine—ABCB1—Prednisone—systemic scleroderma	0.0552	0.107	CbGbCtD
Reboxetine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0413	0.0805	CbGbCtD
Reboxetine—CYP3A4—Prednisone—systemic scleroderma	0.033	0.0644	CbGbCtD
Reboxetine—ABCB1—Methotrexate—systemic scleroderma	0.0277	0.0539	CbGbCtD
Reboxetine—Discomfort—Lisinopril—systemic scleroderma	0.000451	0.000927	CcSEcCtD
Reboxetine—Dyspepsia—Leflunomide—systemic scleroderma	0.000448	0.000921	CcSEcCtD
Reboxetine—Vomiting—Mometasone—systemic scleroderma	0.000447	0.000919	CcSEcCtD
Reboxetine—Dry mouth—Lisinopril—systemic scleroderma	0.000446	0.000917	CcSEcCtD
Reboxetine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000444	0.000913	CcSEcCtD
Reboxetine—Rash—Mometasone—systemic scleroderma	0.000444	0.000912	CcSEcCtD
Reboxetine—Asthenia—Captopril—systemic scleroderma	0.000443	0.000911	CcSEcCtD
Reboxetine—Dermatitis—Mometasone—systemic scleroderma	0.000443	0.000911	CcSEcCtD
Reboxetine—Decreased appetite—Leflunomide—systemic scleroderma	0.000443	0.00091	CcSEcCtD
Reboxetine—Confusional state—Lisinopril—systemic scleroderma	0.000441	0.000907	CcSEcCtD
Reboxetine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000441	0.000906	CcSEcCtD
Reboxetine—Headache—Mometasone—systemic scleroderma	0.000441	0.000906	CcSEcCtD
Reboxetine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00044	0.000904	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00044	0.000904	CcSEcCtD
Reboxetine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000439	0.000903	CcSEcCtD
Reboxetine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000436	0.000896	CcSEcCtD
Reboxetine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000896	CcSEcCtD
Reboxetine—Constipation—Leflunomide—systemic scleroderma	0.000435	0.000895	CcSEcCtD
Reboxetine—Infection—Lisinopril—systemic scleroderma	0.000435	0.000893	CcSEcCtD
Reboxetine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000892	CcSEcCtD
Reboxetine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000433	0.00089	CcSEcCtD
Reboxetine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000432	0.000888	CcSEcCtD
Reboxetine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000887	CcSEcCtD
Reboxetine—Shock—Lisinopril—systemic scleroderma	0.00043	0.000885	CcSEcCtD
Reboxetine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000428	0.000879	CcSEcCtD
Reboxetine—Tachycardia—Lisinopril—systemic scleroderma	0.000427	0.000878	CcSEcCtD
Reboxetine—Abdominal pain—Azathioprine—systemic scleroderma	0.000426	0.000876	CcSEcCtD
Reboxetine—Body temperature increased—Azathioprine—systemic scleroderma	0.000426	0.000876	CcSEcCtD
Reboxetine—Skin disorder—Lisinopril—systemic scleroderma	0.000425	0.000873	CcSEcCtD
Reboxetine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000871	CcSEcCtD
Reboxetine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000423	0.000869	CcSEcCtD
Reboxetine—Diarrhoea—Captopril—systemic scleroderma	0.000423	0.000869	CcSEcCtD
Reboxetine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000422	0.000868	CcSEcCtD
Reboxetine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000867	CcSEcCtD
Reboxetine—Irritability—Methotrexate—systemic scleroderma	0.000422	0.000867	CcSEcCtD
Reboxetine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000866	CcSEcCtD
Reboxetine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000421	0.000865	CcSEcCtD
Reboxetine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00042	0.000864	CcSEcCtD
Reboxetine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00042	0.000862	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000419	0.000862	CcSEcCtD
Reboxetine—Nausea—Mometasone—systemic scleroderma	0.000418	0.000859	CcSEcCtD
Reboxetine—Anorexia—Lisinopril—systemic scleroderma	0.000417	0.000857	CcSEcCtD
Reboxetine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000416	0.000856	CcSEcCtD
Reboxetine—Constipation—Mycophenolic acid—systemic scleroderma	0.000415	0.000854	CcSEcCtD
Reboxetine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000415	0.000853	CcSEcCtD
Reboxetine—Weight decreased—Prednisone—systemic scleroderma	0.000413	0.00085	CcSEcCtD
Reboxetine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000849	CcSEcCtD
Reboxetine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000412	0.000847	CcSEcCtD
Reboxetine—Hypotension—Lisinopril—systemic scleroderma	0.000409	0.00084	CcSEcCtD
Reboxetine—Dizziness—Captopril—systemic scleroderma	0.000409	0.00084	CcSEcCtD
Reboxetine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000408	0.000838	CcSEcCtD
Reboxetine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000406	0.000833	CcSEcCtD
Reboxetine—Urticaria—Leflunomide—systemic scleroderma	0.000405	0.000831	CcSEcCtD
Reboxetine—Abdominal pain—Leflunomide—systemic scleroderma	0.000403	0.000827	CcSEcCtD
Reboxetine—Body temperature increased—Leflunomide—systemic scleroderma	0.000403	0.000827	CcSEcCtD
Reboxetine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0004	0.000823	CcSEcCtD
Reboxetine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000822	CcSEcCtD
Reboxetine—Breast disorder—Methotrexate—systemic scleroderma	0.000399	0.000821	CcSEcCtD
Reboxetine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000819	CcSEcCtD
Reboxetine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000397	0.000816	CcSEcCtD
Reboxetine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000397	0.000816	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000816	CcSEcCtD
Reboxetine—Insomnia—Lisinopril—systemic scleroderma	0.000396	0.000813	CcSEcCtD
Reboxetine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000812	CcSEcCtD
Reboxetine—Paraesthesia—Lisinopril—systemic scleroderma	0.000393	0.000807	CcSEcCtD
Reboxetine—Vomiting—Captopril—systemic scleroderma	0.000393	0.000807	CcSEcCtD
Reboxetine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000804	CcSEcCtD
Reboxetine—Dyspnoea—Lisinopril—systemic scleroderma	0.00039	0.000802	CcSEcCtD
Reboxetine—Rash—Captopril—systemic scleroderma	0.00039	0.000801	CcSEcCtD
Reboxetine—Dermatitis—Captopril—systemic scleroderma	0.000389	0.0008	CcSEcCtD
Reboxetine—Somnolence—Lisinopril—systemic scleroderma	0.000389	0.000799	CcSEcCtD
Reboxetine—Headache—Captopril—systemic scleroderma	0.000387	0.000795	CcSEcCtD
Reboxetine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000387	0.000794	CcSEcCtD
Reboxetine—Dyspepsia—Lisinopril—systemic scleroderma	0.000385	0.000792	CcSEcCtD
Reboxetine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000384	0.000789	CcSEcCtD
Reboxetine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000384	0.000789	CcSEcCtD
Reboxetine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000783	CcSEcCtD
Reboxetine—Decreased appetite—Lisinopril—systemic scleroderma	0.00038	0.000782	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000378	0.000776	CcSEcCtD
Reboxetine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000775	CcSEcCtD
Reboxetine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000773	CcSEcCtD
Reboxetine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000375	0.000771	CcSEcCtD
Reboxetine—Constipation—Lisinopril—systemic scleroderma	0.000374	0.000769	CcSEcCtD
Reboxetine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000769	CcSEcCtD
Reboxetine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000765	CcSEcCtD
Reboxetine—Bradycardia—Prednisone—systemic scleroderma	0.000372	0.000765	CcSEcCtD
Reboxetine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000762	CcSEcCtD
Reboxetine—Diarrhoea—Azathioprine—systemic scleroderma	0.000369	0.000758	CcSEcCtD
Reboxetine—Nausea—Captopril—systemic scleroderma	0.000367	0.000754	CcSEcCtD
Reboxetine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000751	CcSEcCtD
Reboxetine—Asthenia—Leflunomide—systemic scleroderma	0.000365	0.000751	CcSEcCtD
Reboxetine—Hallucination—Prednisone—systemic scleroderma	0.000364	0.000748	CcSEcCtD
Reboxetine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000361	0.000741	CcSEcCtD
Reboxetine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000359	0.000739	CcSEcCtD
Reboxetine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000736	CcSEcCtD
Reboxetine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000358	0.000735	CcSEcCtD
Reboxetine—Dysuria—Methotrexate—systemic scleroderma	0.000357	0.000734	CcSEcCtD
Reboxetine—Dizziness—Azathioprine—systemic scleroderma	0.000357	0.000733	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000352	0.000723	CcSEcCtD
Reboxetine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000349	0.000716	CcSEcCtD
Reboxetine—Diarrhoea—Leflunomide—systemic scleroderma	0.000348	0.000716	CcSEcCtD
Reboxetine—Urticaria—Lisinopril—systemic scleroderma	0.000348	0.000714	CcSEcCtD
Reboxetine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000713	CcSEcCtD
Reboxetine—Abdominal pain—Lisinopril—systemic scleroderma	0.000346	0.000711	CcSEcCtD
Reboxetine—Body temperature increased—Lisinopril—systemic scleroderma	0.000346	0.000711	CcSEcCtD
Reboxetine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000707	CcSEcCtD
Reboxetine—Vomiting—Azathioprine—systemic scleroderma	0.000343	0.000705	CcSEcCtD
Reboxetine—Eye disorder—Prednisone—systemic scleroderma	0.000342	0.000703	CcSEcCtD
Reboxetine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000702	CcSEcCtD
Reboxetine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000341	0.0007	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—systemic scleroderma	0.000341	0.0007	CcSEcCtD
Reboxetine—Infestation—Methotrexate—systemic scleroderma	0.000341	0.0007	CcSEcCtD
Reboxetine—Rash—Azathioprine—systemic scleroderma	0.00034	0.000699	CcSEcCtD
Reboxetine—Dermatitis—Azathioprine—systemic scleroderma	0.00034	0.000698	CcSEcCtD
Reboxetine—Headache—Azathioprine—systemic scleroderma	0.000338	0.000694	CcSEcCtD
Reboxetine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000694	CcSEcCtD
Reboxetine—Dizziness—Leflunomide—systemic scleroderma	0.000337	0.000692	CcSEcCtD
Reboxetine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000685	CcSEcCtD
Reboxetine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000332	0.000683	CcSEcCtD
Reboxetine—Angiopathy—Prednisone—systemic scleroderma	0.000332	0.000682	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000331	0.00068	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00068	CcSEcCtD
Reboxetine—Immune system disorder—Prednisone—systemic scleroderma	0.00033	0.000679	CcSEcCtD
Reboxetine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000674	CcSEcCtD
Reboxetine—Sweating—Methotrexate—systemic scleroderma	0.000326	0.000671	CcSEcCtD
Reboxetine—Vomiting—Leflunomide—systemic scleroderma	0.000324	0.000665	CcSEcCtD
Reboxetine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000322	0.000663	CcSEcCtD
Reboxetine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000321	0.00066	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—systemic scleroderma	0.000321	0.00066	CcSEcCtD
Reboxetine—Rash—Leflunomide—systemic scleroderma	0.000321	0.00066	CcSEcCtD
Reboxetine—Dermatitis—Leflunomide—systemic scleroderma	0.000321	0.000659	CcSEcCtD
Reboxetine—Mental disorder—Prednisone—systemic scleroderma	0.00032	0.000659	CcSEcCtD
Reboxetine—Nausea—Azathioprine—systemic scleroderma	0.00032	0.000658	CcSEcCtD
Reboxetine—Headache—Leflunomide—systemic scleroderma	0.000319	0.000656	CcSEcCtD
Reboxetine—Malnutrition—Prednisone—systemic scleroderma	0.000318	0.000654	CcSEcCtD
Reboxetine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000649	CcSEcCtD
Reboxetine—Asthenia—Lisinopril—systemic scleroderma	0.000314	0.000645	CcSEcCtD
Reboxetine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000644	CcSEcCtD
Reboxetine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000309	0.000635	CcSEcCtD
Reboxetine—Rash—Mycophenolic acid—systemic scleroderma	0.000306	0.000629	CcSEcCtD
Reboxetine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000306	0.000629	CcSEcCtD
Reboxetine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000626	CcSEcCtD
Reboxetine—Headache—Mycophenolic acid—systemic scleroderma	0.000304	0.000625	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—systemic scleroderma	0.000303	0.000624	CcSEcCtD
Reboxetine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000623	CcSEcCtD
Reboxetine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000623	CcSEcCtD
Reboxetine—Nausea—Leflunomide—systemic scleroderma	0.000302	0.000622	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000302	0.00062	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—systemic scleroderma	0.0003	0.000616	CcSEcCtD
Reboxetine—Diarrhoea—Lisinopril—systemic scleroderma	0.000299	0.000615	CcSEcCtD
Reboxetine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000295	0.000607	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—systemic scleroderma	0.000295	0.000605	CcSEcCtD
Reboxetine—Anaemia—Prednisone—systemic scleroderma	0.000294	0.000605	CcSEcCtD
Reboxetine—Agitation—Prednisone—systemic scleroderma	0.000293	0.000601	CcSEcCtD
Reboxetine—Dizziness—Lisinopril—systemic scleroderma	0.000289	0.000595	CcSEcCtD
Reboxetine—Nausea—Mycophenolic acid—systemic scleroderma	0.000289	0.000593	CcSEcCtD
Reboxetine—Malaise—Prednisone—systemic scleroderma	0.000287	0.00059	CcSEcCtD
Reboxetine—Vertigo—Prednisone—systemic scleroderma	0.000286	0.000588	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—systemic scleroderma	0.000286	0.000587	CcSEcCtD
Reboxetine—Syncope—Prednisone—systemic scleroderma	0.000286	0.000587	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—systemic scleroderma	0.000285	0.000586	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000284	0.000583	CcSEcCtD
Reboxetine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00058	CcSEcCtD
Reboxetine—Loss of consciousness—Prednisone—systemic scleroderma	0.00028	0.000575	CcSEcCtD
Reboxetine—Vomiting—Lisinopril—systemic scleroderma	0.000278	0.000572	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—systemic scleroderma	0.000277	0.00057	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—systemic scleroderma	0.000276	0.000567	CcSEcCtD
Reboxetine—Rash—Lisinopril—systemic scleroderma	0.000276	0.000567	CcSEcCtD
Reboxetine—Dermatitis—Lisinopril—systemic scleroderma	0.000276	0.000566	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000275	0.000566	CcSEcCtD
Reboxetine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000565	CcSEcCtD
Reboxetine—Hypertension—Prednisone—systemic scleroderma	0.000275	0.000565	CcSEcCtD
Reboxetine—Chills—Methotrexate—systemic scleroderma	0.000274	0.000564	CcSEcCtD
Reboxetine—Headache—Lisinopril—systemic scleroderma	0.000274	0.000563	CcSEcCtD
Reboxetine—Anxiety—Prednisone—systemic scleroderma	0.00027	0.000555	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000269	0.000553	CcSEcCtD
Reboxetine—Discomfort—Prednisone—systemic scleroderma	0.000268	0.00055	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—systemic scleroderma	0.000268	0.00055	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—systemic scleroderma	0.000266	0.000547	CcSEcCtD
Reboxetine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000539	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—systemic scleroderma	0.000261	0.000536	CcSEcCtD
Reboxetine—Nausea—Lisinopril—systemic scleroderma	0.00026	0.000534	CcSEcCtD
Reboxetine—Infection—Prednisone—systemic scleroderma	0.000258	0.000531	CcSEcCtD
Reboxetine—Shock—Prednisone—systemic scleroderma	0.000256	0.000525	CcSEcCtD
Reboxetine—Nervous system disorder—Prednisone—systemic scleroderma	0.000255	0.000524	CcSEcCtD
Reboxetine—Tachycardia—Prednisone—systemic scleroderma	0.000254	0.000521	CcSEcCtD
Reboxetine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000521	CcSEcCtD
Reboxetine—Skin disorder—Prednisone—systemic scleroderma	0.000252	0.000519	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000251	0.000516	CcSEcCtD
Reboxetine—Anorexia—Prednisone—systemic scleroderma	0.000248	0.000509	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000247	0.000507	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—systemic scleroderma	0.000246	0.000505	CcSEcCtD
Reboxetine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000501	CcSEcCtD
Reboxetine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000497	CcSEcCtD
Reboxetine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000496	CcSEcCtD
Reboxetine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000494	CcSEcCtD
Reboxetine—Malaise—Methotrexate—systemic scleroderma	0.00024	0.000493	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—systemic scleroderma	0.000239	0.000491	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—systemic scleroderma	0.000238	0.00049	CcSEcCtD
Reboxetine—Insomnia—Prednisone—systemic scleroderma	0.000235	0.000483	CcSEcCtD
Reboxetine—Paraesthesia—Prednisone—systemic scleroderma	0.000233	0.00048	CcSEcCtD
Reboxetine—Dyspepsia—Prednisone—systemic scleroderma	0.000229	0.00047	CcSEcCtD
Reboxetine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000468	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—systemic scleroderma	0.000227	0.000466	CcSEcCtD
Reboxetine—Decreased appetite—Prednisone—systemic scleroderma	0.000226	0.000464	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000225	0.000462	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—systemic scleroderma	0.000224	0.00046	CcSEcCtD
Reboxetine—Constipation—Prednisone—systemic scleroderma	0.000222	0.000457	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—systemic scleroderma	0.000219	0.00045	CcSEcCtD
Reboxetine—Infection—Methotrexate—systemic scleroderma	0.000216	0.000443	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisone—systemic scleroderma	0.000214	0.00044	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000213	0.000438	CcSEcCtD
Reboxetine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000212	0.000437	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—systemic scleroderma	0.000211	0.000434	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00021	0.000431	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—systemic scleroderma	0.000207	0.000425	CcSEcCtD
Reboxetine—Urticaria—Prednisone—systemic scleroderma	0.000206	0.000424	CcSEcCtD
Reboxetine—Abdominal pain—Prednisone—systemic scleroderma	0.000205	0.000422	CcSEcCtD
Reboxetine—Body temperature increased—Prednisone—systemic scleroderma	0.000205	0.000422	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—systemic scleroderma	0.000203	0.000417	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—systemic scleroderma	0.000196	0.000404	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—systemic scleroderma	0.000195	0.000401	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—systemic scleroderma	0.000194	0.000398	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—systemic scleroderma	0.000193	0.000397	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisone—systemic scleroderma	0.000191	0.000393	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—systemic scleroderma	0.000191	0.000393	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—systemic scleroderma	0.000189	0.000388	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000187	0.000385	CcSEcCtD
Reboxetine—Asthenia—Prednisone—systemic scleroderma	0.000186	0.000383	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000179	0.000368	CcSEcCtD
Reboxetine—Diarrhoea—Prednisone—systemic scleroderma	0.000178	0.000365	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000178	0.000365	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—systemic scleroderma	0.000173	0.000355	CcSEcCtD
Reboxetine—Dizziness—Prednisone—systemic scleroderma	0.000172	0.000353	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—systemic scleroderma	0.000172	0.000353	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—systemic scleroderma	0.000172	0.000353	CcSEcCtD
Reboxetine—Vomiting—Prednisone—systemic scleroderma	0.000165	0.00034	CcSEcCtD
Reboxetine—Rash—Prednisone—systemic scleroderma	0.000164	0.000337	CcSEcCtD
Reboxetine—Dermatitis—Prednisone—systemic scleroderma	0.000164	0.000336	CcSEcCtD
Reboxetine—Headache—Prednisone—systemic scleroderma	0.000163	0.000335	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00016	0.000329	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—systemic scleroderma	0.000156	0.00032	CcSEcCtD
Reboxetine—Nausea—Prednisone—systemic scleroderma	0.000154	0.000317	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—systemic scleroderma	0.000149	0.000305	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—systemic scleroderma	0.000144	0.000295	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—systemic scleroderma	0.000138	0.000284	CcSEcCtD
Reboxetine—Rash—Methotrexate—systemic scleroderma	0.000137	0.000281	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—systemic scleroderma	0.000137	0.000281	CcSEcCtD
Reboxetine—Headache—Methotrexate—systemic scleroderma	0.000136	0.00028	CcSEcCtD
Reboxetine—Nausea—Methotrexate—systemic scleroderma	0.000129	0.000265	CcSEcCtD
